Valuation: Illumina, Inc.

Market Cap 40.12B 35.64B 33.33B 30.37B 57.18B 3,863B 57.96B 403B 156B 1,967B 151B 147B 6,319B P/E 2026 *
53.7x
P/E 2027 * 44.9x
Enterprise Value 40.01B 35.54B 33.23B 30.28B 57.01B 3,852B 57.8B 402B 156B 1,962B 150B 147B 6,301B EV / Sales 2026 *
8.65x
EV / Sales 2027 * 7.96x
Free-Float
74.97%
Yield 2026 *
-
Yield 2027 * -
1 day-2.91%
1 week-2.99%
Current month-2.91%
1 month+28.29%
3 months+44.50%
6 months+109.84%
Current year+102.59%
1 week 262.89
Extreme 262.89
280.16
1 month 200.01
Extreme 200.01
280.16
Current year 112.65
Extreme 112.65
280.16
1 year 88
Extreme 88
280.16
3 years 68.7
Extreme 68.7
280.16
5 years 68.7
Extreme 68.7
428
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer 55 28/05/2025
Director TitleAgeSince
Director/Board Member 65 27/07/2016
Director/Board Member 66 31/12/2016
Director/Board Member 65 04/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
08/09/26 Free

General Counsel

29,377 0.0195%
05/09/26 Tax

Chief Technology Officer

-408 0.0003%
04/09/26
Corvex Management LP
SellCompany -119,501 0.0791%
Change 5-day change 1-year change 3-year change Capi.($)
-2.91%-2.99%+159.85%+93.56% 40.12B
-3.34%-3.81%+22.95%+28.91% 241B
-4.42%-5.37%-0.53%-14.65% 149B
-1.33%+0.43%-8.40%+37.27% 142B
-0.96%-3.25%-54.90%-18.12% 62.65B
-1.31%-0.63%+11.64%+22.96% 49.1B
-3.27%-3.56%+20.28%+49.06% 46.99B
+0.60%-0.13%-19.55%-21.49% 47.13B
-1.23%+2.58%-3.86%+38.57% 45.65B
-3.15%-1.11%+33.06%+55.18% 41.81B
Average -1.84%-0.04%+16.05%+27.13% 86.53B
Weighted average by Cap. -2.21%+0.29%+10.46%+22.17%

Financials

2026 *2027 *
Net sales 4.62B 4.11B 3.84B 3.5B 6.59B 445B 6.68B 46.46B 17.99B 227B 17.36B 16.98B 728B 4.92B 4.37B 4.09B 3.72B 7.01B 474B 7.11B 49.44B 19.14B 241B 18.47B 18.07B 775B
Net income 772M 686M 641M 584M 1.1B 74.35B 1.12B 7.76B 3B 37.86B 2.9B 2.84B 122B 912M 810M 757M 690M 1.3B 87.77B 1.32B 9.16B 3.55B 44.7B 3.42B 3.35B 144B
Net Debt -116M -103M -96.02M -87.5M -165M -11.13B -167M -1.16B -450M -5.67B -434M -425M -18.21B -976M -867M -811M -739M -1.39B -93.97B -1.41B -9.81B -3.8B -47.86B -3.66B -3.59B -154B
Logo Illumina, Inc.
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (85.4%): tools and instruments for sequencing, genotyping, genetic expression, etc.; - sales of services (14.6%). Net sales are distributed geographically as follows: the United States (51.6%), Americas (3.8%), Europe (29.1%), Asia/Pacific/Middle East/Africa (9.9%) and China/Taiwan/Hong Kong (5.6%).
Employees
8,625
Date Price Change Volume
01/10/26 US$265.72 -2.91% 1,951,226
30/09/26 US$273.68 +0.62% 2,939,286
29/09/26 US$272.00 +0.04% 2,229,743
28/09/26 US$271.90 +0.70% 2,980,164
25/09/26 US$270.00 -1.42% 5,031,975
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
265.72USD
Average target price
210.65USD
Spread / Average Target
-20.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock